Recent studies have found that SRF can effectively inhibit the proliferation and promote the apoptosis of HSCs, which provides new horizons for the treatment of liver fibrosis (Wang et al., 2010; Ganten et al., 2017; Su et al., 2018). The gene discussed is SRF; the disease is Hepatic fibrosis.